The upregulation of Notch ligand JAG1 and targets Hey1, Hey2, Hes1 in brain tissues of glioma patients compared to that of healthy brain tissues also highlight the Notch signaling pathway as a potential therapeutic target in glioma patients (El Hindy et al., 2013). Here, HES1 is linked to central nervous system cancer.